Jump to main content
Jump to site search

Issue 45, 2016
Previous Article Next Article

Melanin nanoparticles as an endogenous agent for efficient iron overload therapy

Author affiliations

Abstract

Improving iron-chelating drugs for the safe and efficient therapy of iron overload disease is greatly challenging and highly desired. Endogenous iron chelators are perfect candidates because of their intrinsic biodegradability and biocompatibility, which avoid the severe side effects of the exogenous drugs currently present in clinical applications. Herein, for the first time, we have reported simply using melanin nanoparticles as an efficient natural nano-drug for iron overload therapy in living mice. Its native biocompatibility, biodegradability, high iron-capturing volume and long circulation time endow it with a lower required dosage quantity and frequency, but it accomplishes better therapeutic effects than the traditional drug deferoxamine (DFO).

Graphical abstract: Melanin nanoparticles as an endogenous agent for efficient iron overload therapy

Back to tab navigation

Supplementary files

Publication details

The article was received on 24 Jun 2016, accepted on 14 Oct 2016 and first published on 14 Oct 2016


Article type: Paper
DOI: 10.1039/C6TB01558A
Citation: J. Mater. Chem. B, 2016,4, 7233-7240
  •   Request permissions

    Melanin nanoparticles as an endogenous agent for efficient iron overload therapy

    J. Yan, Y. Ji, P. Zhang, X. Lu, Q. Fan, D. Pan, R. Yang, Y. Xu, L. Wang, L. Zhang and M. Yang, J. Mater. Chem. B, 2016, 4, 7233
    DOI: 10.1039/C6TB01558A

Search articles by author

Spotlight

Advertisements